LyP-1, Peptide 1 – 1 mg

Overview

LyP-1, also known as Peptide 1, is an innovative peptide used primarily in the detection of lymphatics and tumor cells associated with certain tumors. Unlike other peptides, LyP-1 specifically targets lymphatics and tumor cells while avoiding lymphatics in normal tissues. This specificity makes it an essential tool for researchers focusing on cancer detection and treatment.

Key Features

• Recognizes lymphatics and tumor cells in specific tumors.
• Does not target lymphatics in normal tissues.
• Positive screening results on breast carcinoma xenografts.
• Efficient detection in osteosarcoma xenografts.
• Identifies spontaneous prostate and breast cancers in transgenic mice.
• Accumulates in the nuclei of tumor structures with various lymphatic endothelial markers.

Specifications

FAQ

What types of tumors does LyP-1 recognize?

LyP-1 recognizes specific tumors such as breast carcinoma, osteosarcoma, and spontaneous prostate and breast cancers in transgenic mice.

How does LyP-1 differ from other peptides?

LyP-1 is unique in that it specifically targets lymphatics and tumor cells without affecting normal tissue lymphatics, making it ideal for targeted cancer studies.

Where can I find more information on related research products?

You can explore more about various peptides and their applications in cancer research on our website.

For those looking to enhance their research on protein interactions, consider exploring our offerings like PKG Substrate and Autocamtide-2. These kits complement the unique applications of LyP-1, helping to provide precise results in your research.

Order your LyP-1, Peptide 1 today and take a step forward in your research on lymphatic systems and cancer detection.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled